We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.33%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,055

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTB
3476
HomeTrust Bancshares
HTB
$831M
-32,913
Closed -$727K
XAGE
3477
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
-340
Closed -$100K
MKFG
3478
DELISTED
Markforged Holding Corporation
MKFG
-3,452
Closed -$68K
WBX.WS
3479
CALL
DELISTED
Wallbox N.V. Warrants, each warrant to purchase one Class A Ordinary Share
WBX.WS
-168,532
Closed -$1.33M
ML.WS
3480
CALL
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
-121,227
Closed -$108K
ACCD
3481
DELISTED
Accolade Inc
ACCD
-47,184
Closed -$539K
LGTY
3482
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-22,482
Closed -$345K
GATE
3483
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
-1,482,396
Closed -$14.8M
SASR
3484
DELISTED
Sandy Spring Bancorp Inc
SASR
-6,407
Closed -$226K
RDW.WS
3485
CALL
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
-223,754
Closed -$533K
WINV
3486
DELISTED
WinVest Acquisition Corp. Common Stock
WINV
-569,078
Closed -$5.71M
AZPN
3487
DELISTED
Aspen Technology Inc
AZPN
-5,768
Closed -$1.37M
CFB
3488
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
-24,929
Closed -$325K
SUM
3489
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-114,234
Closed -$2.69M
RVNC
3490
DELISTED
Revance Therapeutics, Inc.
RVNC
-41,253
Closed -$1.11M
BCOV
3491
DELISTED
Brightcove, Inc.
BCOV
-15,517
Closed -$98K
ENLC
3492
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
-10,825
Closed -$96K
SMAR
3493
DELISTED
Smartsheet Inc.
SMAR
-50,454
Closed -$1.73M
MMVWW
3494
CALL
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
-140,000
Closed -$1.45M
ASAI
3495
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
-38,964
Closed -$630K
AKTS
3496
DELISTED
Akoustis Technologies Inc
AKTS
-10,853
Closed -$33K
MRO
3497
DELISTED
Marathon Oil Corporation
MRO
-231,689
Closed -$5.23M
EVTL.WS
3498
CALL
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
-370,926
Closed -$3.47M
PRMW
3499
DELISTED
Primo Water Corporation
PRMW
-393,794
Closed -$4.94M
GRDI
3500
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
-1,244,840
Closed -$12.3M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,055 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,055 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.